Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott L Carter

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|October 9, 2014
Response and acquired resistance to everolimus in anaplastic thyroid cancerNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Plos One|June 9, 2017
Systematic genomic and translational efficiency studies of uveal melanomaChelsea Place Johnson, Ivana K Kim, Bita Esmaeli, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Nature Communications|December 21, 2017
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancerDavid Liu, Philip Abbosh, Daniel Keliher, et al.
Nature Genetics|July 21, 2015
Paired exome analysis of Barrett's esophagus and adenocarcinomaMatthew D Stachler, Amaro Taylor-Weiner, Shouyong Peng, et al.
Cell|February 19, 2013
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaDan A Landau, Scott L Carter, Petar Stojanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
JAMA Oncology|July 17, 2015
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaEliezer M Van Allen, Vivian W Y Lui, Ann Marie Egloff, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|October 9, 2014
Response and acquired resistance to everolimus in anaplastic thyroid cancerNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Plos One|June 9, 2017
Systematic genomic and translational efficiency studies of uveal melanomaChelsea Place Johnson, Ivana K Kim, Bita Esmaeli, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Nature Communications|December 21, 2017
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancerDavid Liu, Philip Abbosh, Daniel Keliher, et al.
Nature Genetics|July 21, 2015
Paired exome analysis of Barrett's esophagus and adenocarcinomaMatthew D Stachler, Amaro Taylor-Weiner, Shouyong Peng, et al.
Cell|February 19, 2013
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaDan A Landau, Scott L Carter, Petar Stojanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
JAMA Oncology|July 17, 2015
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaEliezer M Van Allen, Vivian W Y Lui, Ann Marie Egloff, et al.
Pageof 8